WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 9 fonti

FDA approves long-lasting HIV-prevention drug - UPI.com

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

Raccontata dausatoday.comcnbc.comilsole24ore.comhuffpost.comupi.comscmp.comansa.itrepubblica.itwired.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
upi.comStai leggendo1 anni fa

FDA approves long-lasting HIV-prevention drug - UPI.com

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

originale

Timeline cronologica

  1. mercoledì 18 giugno 2025·usatoday.com

    FDA approves new twice-yearly HIV shot. What to know

    The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

  2. mercoledì 18 giugno 2025·cnbc.com

    FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

    The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts. 

usatoday.com
1 anni fa

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Leggi questa versione → originale
cnbc.com1 anni fa

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts. 

Leggi questa versione → originale
scmp.com1 anni fa

US approves Gilead’s twice-yearly shot for HIV prevention

Lenacapavir was nearly 100 per cent effective in preventing HIV in clinical trials.

Leggi questa versione → originale
huffpost.com1 anni fa

The FDA Approves Powerful HIV Prevention Drug

But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.

Leggi questa versione → originale
wired.com1 anni fa

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

Leggi questa versione → originale
  • mercoledì 18 giugno 2025·ilsole24ore.com

    Approvata la prima iniezione semestrale per prevenire l’Hiv. «È la cosa più vicina a un vaccino»

    Ok dell’Fda al farmaco che si somministra solo due volte l’anno e potrebbe segnare un punto di svolta nella lotta a una pandemia che dura da oltre quattro decenni

  • giovedì 19 giugno 2025·huffpost.com

    The FDA Approves Powerful HIV Prevention Drug

    But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.

  • giovedì 19 giugno 2025·upi.com

    FDA approves long-lasting HIV-prevention drug - UPI.com

    The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and possibly eradicate the disease.

  • giovedì 19 giugno 2025·scmp.com

    US approves Gilead’s twice-yearly shot for HIV prevention

    Lenacapavir was nearly 100 per cent effective in preventing HIV in clinical trials.

  • giovedì 19 giugno 2025·ansa.it

    Fda Usa approva un nuovo farmaco per prevenire l'Aids - Sanità - Ansa.it

    La Food and Drug Administration (Fda) americana ha approvato un nuovo farmaco che potrebbe contribuire a mettere fine all'epidemia di Aids. Si tratta di un'iniezione antivirale…

  • giovedì 19 giugno 2025·repubblica.it

    Rivoluzione Hiv: la Fda approva le due iniezioni l’anno per prevenire l’infezione

    Il lancio del lenacapavir potrà cambiare il corso dell’epidemia di Aids. Ma dovrà affrontare tuttavia i tagli proposti dall'amministrazione Trump ai finanziame…

  • venerdì 20 giugno 2025·wired.com

    The FDA Just Approved a Long-Lasting Injection to Prevent HIV

    Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the…